Noah Knauf | General Partner, BOND Capital Co-founded BOND with Mary Meeker in 2019 | $2.5B Fund III closed $1.8B deployed across 18 companies at Warburg Pincus | 9 years, 3 major exits Stanford GSB Arjay Miller Scholar | Top 10% of graduating class Portfolio: AKASA · Saildrone · Sidecar Health · Sunday · Beam Dental | San Francisco Crypto investor since 2016 | Focused on healthcare · fintech · gaming · frontier tech Noah Knauf | General Partner, BOND Capital Co-founded BOND with Mary Meeker in 2019 | $2.5B Fund III closed $1.8B deployed across 18 companies at Warburg Pincus | 9 years, 3 major exits Stanford GSB Arjay Miller Scholar | Top 10% of graduating class Portfolio: AKASA · Saildrone · Sidecar Health · Sunday · Beam Dental | San Francisco Crypto investor since 2016 | Focused on healthcare · fintech · gaming · frontier tech
Noah Knauf, General Partner at BOND Capital
Venture Capital / San Francisco

Noah Knauf

General Partner & Co-Founder - BOND Capital

When Mary Meeker decided to leave Kleiner Perkins and build something new, Noah Knauf was one of the people she called. Together they launched BOND Capital in January 2019 - now one of the highest-profile growth-stage firms in Silicon Valley, with funds totaling more than $4 billion.

BOND Capital Growth Equity Stanford GSB Arjay Miller Scholar Warburg Pincus
$1.8B
Deployed at Warburg Pincus
18
Companies at Warburg
$2.5B
BOND Fund III (2022)
20+
Years in Finance & VC
Profile
The GP Who Builds with Meeker

Most venture investors in San Francisco can trace their origin story to a single "aha" moment - a founder they believed in, a deal that almost didn't close. Noah Knauf's story is quieter and more methodical than that. He starts with the numbers. He started at Bain, moved to private equity at Parthenon, spent nine years at Warburg Pincus learning to write very large checks, then joined Kleiner Perkins, then left with Mary Meeker to start something entirely new. Twenty-plus years of compounding conviction.

At BOND Capital, Knauf focuses on healthcare, fintech, gaming, and frontier technology - sectors where he can draw on his private equity background to evaluate businesses that already have scale, complexity, and real operational leverage. His seat on the boards of AKASA, Saildrone, Sidecar Health, and Sunday reflects that range: AI-powered healthcare revenue cycle management, autonomous ocean drones, health insurance for the uninsured, and home services, respectively. Not a single thesis. A framework for finding durable growth wherever it appears.

The firm raised $1.25 billion in less than four months for Fund I. Not because of hype. Because Mary Meeker's data-driven internet report had been shaping how institutional investors think about technology for 25 years.

BOND Capital - Fund I, 2019

BOND launched in January 2019 as a spinout of the Kleiner Perkins Digital Growth Fund. Knauf was one of four co-founders alongside Meeker, Mood Rowghani, and Juliet de Baubigny. The firm's model is deliberately different from Sand Hill Road convention: fewer bets, larger positions, a longer holding horizon, and an obsession with proprietary data analysis that Meeker pioneered through her annual Internet Report. Knauf was hired into that framework at KPCB in 2016, and helped transplant it into an independent firm.

By April 2022, BOND had closed its third fund at $2.5 billion - bringing estimated assets under management toward $5 billion. For a firm not yet six years old, that trajectory is unusual. For a firm anchored by one of the most recognized names in technology investing and staffed by GPs with genuine operational depth, it was perhaps the only predictable thing about it.

The crypto angle is less widely known. On X, Knauf identifies himself as a "crypto investor since 2016" - which predates Bitcoin's first major retail peak and puts him in the early adopter tier among institutional investors. It also points to a willingness to engage with discomfort that his career otherwise understates: the man spent nine years at Warburg Pincus, a firm not exactly known for hot takes.

Career Arc
From Bain to BOND
2001 - 2003
Bain & Company - Consultant
The first toolkit: rigorous analysis, frameworks for evaluating businesses under pressure, and the discipline of translating data into decisions. A classic start for future investors.
2003 - 2005
Parthenon Capital - Associate
Private equity, early exposure. Learning the mechanics of growth equity investing before the terminology became fashionable.
2005 - 2016
Warburg Pincus - Managing Director
Nine years. $1.8 billion deployed across 18 companies. Focus on medical technology, specialty pharmaceuticals, and healthcare services. Three significant exits: Constitution Medical (Roche), Lutonix (Bard), JHP Pharmaceuticals (Par). Also co-led the formation of Helix, the Illumina partnership for consumer genomics.
2016 - 2018
Kleiner Perkins - General Partner
Joined Mary Meeker's digital growth practice. Handpicked to join the team managing the Digital Growth Fund alongside Meeker, Ted Schlein, and Mood Rowghani. The transition from private equity managing director to Silicon Valley GP.
2019 - Present
BOND Capital - Co-Founder & General Partner
Spinout from Kleiner Perkins. Launched January 2019 with Mary Meeker, Mood Rowghani, and Juliet de Baubigny. Fund I: $1.25B in under four months. Fund III: $2.5B (April 2022). Current board seats: AKASA, Saildrone, Sidecar Health, Sunday.
Deep Dive
The Warburg Years: $1.8 Billion, 9 Years

Nine years at Warburg Pincus is a long time in any industry. In private equity, it means you have lived through a full investment cycle - or two. Knauf joined as a managing director focused on technology-enabled businesses, with a particular lens on the healthcare sector. By the time he left in 2016, he had deployed $1.8 billion across 18 companies and had three successful exits to his name.

The Warburg exits tell a particular story about his approach. Constitution Medical was acquired by Roche - a large-cap pharma acquirer buying capabilities it couldn't build fast enough. Lutonix was picked up by C.R. Bard, a medical device company plugging a gap in its cardiovascular portfolio. JHP Pharmaceuticals landed at Par Pharmaceutical. None of these were flashy consumer internet deals. They were operational businesses with real margins, real competitors, and real integration risk. The acquirers ran the numbers and bought them anyway.

The outlier in Knauf's Warburg tenure was Helix - a consumer genomics platform he co-led forming in partnership with Illumina. It was 2015, genomics was becoming affordable, and the bet was that consumers would want to unlock data about themselves the way they unlocked their smartphones. Helix later raised significant follow-on rounds and pivoted toward population genomics. The original thesis wasn't entirely wrong - it was early.

Constitution Medical
Digital hematology - automated blood cell analysis
Acquired by Roche
Lutonix
Drug-coated balloon catheters for peripheral vascular disease
Acquired by Bard
JHP Pharmaceuticals
Specialty injectable pharmaceutical manufacturer
Acquired by Par
Helix
Consumer genomics platform, Illumina partnership
Co-Founded

Selected highlights from Warburg Pincus tenure 2005-2016

Current Portfolio
Board Seats at BOND
Fund I
$1.25B
Closed 2019 (in <4 months)
Fund II
~$1.75B
2020-2021
Fund III
$2.5B
Closed April 2022
AKASA
AI / Healthcare Revenue Cycle
AI-native revenue cycle automation for health systems. Automates coding, claims, and billing workflows that traditionally require large administrative teams. BOND led the Series B.
Saildrone
Frontier Tech / Autonomous Ocean
Autonomous wind-powered ocean drones for data collection. Clients include NOAA, the U.S. Navy, and commercial energy companies. Saildrone vessels have crossed the Atlantic and circled Antarctica.
Sidecar Health
Healthtech / Insurance
Health insurance for the uninsured and underinsured, designed around cash-pay pricing. Brings price transparency to a market historically defined by opacity.
Sunday
Consumer / Home Services
Lawn care subscription service using data-driven soil analysis to deliver customized nutrient plans. Sells direct to consumers with a science-backed, sustainability-oriented pitch.
Beam Dental
Insurtech / Dental
Dental insurance that uses connected toothbrushes to monitor oral hygiene and reward good habits with lower premiums. Behavioral health meets actuarial science.
N3twork
Gaming / Mobile
Mobile gaming studio and technology platform. Founded by gaming veterans, focused on building chart-topping titles and licensing its engine to other developers.
Education
Built on Two Disciplines
MBA
Stanford University Graduate School of Business
Arjay Miller Scholar - Top 10% of Graduating Class

Stanford GSB's Arjay Miller Scholars program recognizes graduating students in the top 10% of their class. It's a meaningful signal in a program where everyone starts competitive. Knauf earned it, then went directly into private equity.

B.S.B.A. in Management Information Systems & Operations Management
University of Arizona, Eller College of Management
Dual Focus: Tech + Ops

An undergraduate degree that straddled information systems and operations - technology on one axis, execution on the other. An unusual combination for someone who would later evaluate technology-enabled businesses at the intersection of both.

Dispatch from the Details
Five Things Worth Knowing
2016
Year Knauf started investing in crypto - before Bitcoin's first major mainstream moment. He now identifies it as part of his public bio on X.
$100M
Average deal size at Warburg Pincus. $1.8B across 18 companies over nine years. The math implies a very deliberate, very concentrated portfolio.
Top 10%
Stanford GSB Arjay Miller Scholar designation. Earned in one of the most competitive MBA programs in the world, then immediately put to work in private equity.
<4 mo
How fast BOND raised its first fund. $1.25 billion from institutional investors who had trusted Mary Meeker's internet reports for decades and were ready to back her firm.
Jan 2023
When Knauf joined X/Twitter - relatively late for a Silicon Valley GP. First tweet described himself as a research partner, not just an investor. The self-framing is precise.
Share this profile